UK open data stance: bold or brash?

Share this article:

A UK proposal to make anonymous patient data available for pharma company research elicited cheers and jeers.

Part of a package of reforms unveiled by prime minister David Cameron last month, the proposal was intended to integrate medical research more closely with the NHS and biopharma.

Such drugmakers as Glaxo­SmithKline, as well as academics, hailed Cameron's plan. With privacy safeguards, “access to real data on patient treatment…could help to cut drug development costs and spur rapid innovation,” wrote the Financial Times in an op-ed.

However, medical societies and others warned that data could still include age profiles and post codes, which can be used to trace identities. “We are concerned that elements of the government's proposals could, if implemented, undermine patient confidentiality,” said the British Medical Association in a statement.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.